Cramer’s Got an Appetite for Buffalo Wild Wings, Diageo, and These 2 Stocks

Jim Cramer made the following calls on July 31st, 2013. What do you think about his picks?

Buffalo Wild Wings Inc. (NASDAQ:BWLD): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on April 26, 2013. The stock’s 52-week high is $106.03, and its 52-week low is $69.72.

Sally Smith, chief executive officer of Buffalo Wild Wings, came on Mad Money last night to talk to Cramer about the state of her business. Buffalo Wild Wings posted earnings which beat the street substantially, by $0.09 per share to be exact. The business was able to keep its operating costs low, and continues investing in the future, preparing to open 5 restaurants in the Philippines and opening a concept restaurant next year.

bwld-20130801

Diageo plc (NYSE:DEO): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on December 3, 2012. The stock’s 52-week high is $127.51, and its 52-week low is $105.70.

Diageo was part of a larger trend by investors moving into alcohol, as companies like Boston Beer (NYSE:SAM) are doing well on strong earnings. Diageo has been slowed a bit by the slowdown in China, but Chief Executive Officer Ivan Menezes told CNBC that he was optimistic, “There’s no question the dynamics in China have slowed down but our overall business is up 8 percent in China. We’re very pleased with the momentum we’ve got in our super deluxe scotch whiskey business there, it’s actually up 44 percent.”

deo-20130801

Celgene Corporation (NASDAQ:CELG): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on July 25, 2013. The stock’s 52-week high is $148.98, and its 52-week low is $66.87.

Celgene is a frequent buy recommendation from Cramer, as he likes the biotech space. Celgene is trading within cents of its 52-week high in pre-market trading today, after continued momentum from its earnings push the stock forward. Product sales were up 17 percent year over year, reaching $1.56 billion.

celg-20130801

CVS Caremark Corporation (NYSE:CVS): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on July 25, 2013. The stock’s 52-week high is $62.36, and its 52-week low is $43.65.

Cramer was concise during the lightning round when discussing CVS, saying simply that, “I think that CVS is terrific.” Company earnings are due out August 6th. CVS raised its dividend earlier this month, announcing a new payout of $0.225 per share.

cvs-20130801

Don’t Miss: Should Amazon Be Worried about Overstock?